Constructing Synthetic Treatment Groups without the Mean Exchangeability Assumption

• URL: http://arxiv.org/abs/2309.16409v1
• Date: Thu, 28 Sep 2023 13:00:56 GMT
• Title: Constructing Synthetic Treatment Groups without the Mean Exchangeability Assumption
• Authors: Yuhang Zhang, Yue Liu, Zhihua Zhang
• Abstract summary: We construct a synthetic treatment group for the target population by a weighted mixture of treatment groups of source populations. We establish the normality of the synthetic treatment group based on the sieve semiparametric theory.
• Score: 32.849140378576095
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: The purpose of this work is to transport the information from multiple randomized controlled trials to the target population where we only have the control group data. Previous works rely critically on the mean exchangeability assumption. However, as pointed out by many current studies, the mean exchangeability assumption might be violated. Motivated by the synthetic control method, we construct a synthetic treatment group for the target population by a weighted mixture of treatment groups of source populations. We estimate the weights by minimizing the conditional maximum mean discrepancy between the weighted control groups of source populations and the target population. We establish the asymptotic normality of the synthetic treatment group estimator based on the sieve semiparametric theory. Our method can serve as a novel complementary approach when the mean exchangeability assumption is violated. Experiments are conducted on synthetic and real-world datasets to demonstrate the effectiveness of our methods.

Related papers

• Distributional Treatment Effect Estimation across Heterogeneous Sites via Optimal Transport [23.093484580587074]
  We propose a novel framework for synthesizing counterfactual treatment group data in a target site.<n>Our approach adopts a distributional causal inference perspective by modeling treatment and control as distinct probability measures on the source and target sites.
  arXiv  Detail & Related papers  (2025-11-12T21:42:11Z)
• Causal Clustering for Conditional Average Treatment Effects Estimation and Subgroup Discovery [5.669361767058639]
  Estimating heterogeneous treatment effects is critical in domains such as personalized medicine, resource allocation, and policy evaluation.<n>We propose a novel framework that clusters individuals based on estimated treatment effects using a learned kernel derived from causal forests.
  arXiv  Detail & Related papers  (2025-09-06T17:01:23Z)
• Towards Regulatory-Confirmed Adaptive Clinical Trials: Machine Learning Opportunities and Solutions [59.28853595868749]
  We introduce two new objectives for future clinical trials that integrate regulatory constraints and treatment policy value for both the entire population and under-served populations. We formulate Randomize First Augment Next (RFAN), a new framework for designing Phase III clinical trials. Our framework consists of a standard randomized component followed by an adaptive one, jointly meant to efficiently and safely acquire and assign patients into treatment arms during the trial.
  arXiv  Detail & Related papers  (2025-03-12T10:17:54Z)
• Accounting for Missing Covariates in Heterogeneous Treatment Estimation [17.09751619857397]
  We introduce a novel partial identification strategy based on ideas from ecological inference. We show that our framework can produce bounds that are much tighter than would otherwise be possible.
  arXiv  Detail & Related papers  (2024-10-21T05:47:07Z)
• Heterogeneous Treatment Effects in Panel Data [1.5535138991304305]
  We propose and evaluate a new method that partitions observations into disjoint clusters with similar treatment effects using a regression tree. Our theoretical results establish the convergence of the resulting estimates to the true treatment effects.
  arXiv  Detail & Related papers  (2024-06-09T04:02:08Z)
• Collaborative Heterogeneous Causal Inference Beyond Meta-analysis [68.4474531911361]
  We propose a collaborative inverse propensity score estimator for causal inference with heterogeneous data. Our method shows significant improvements over the methods based on meta-analysis when heterogeneity increases.
  arXiv  Detail & Related papers  (2024-04-24T09:04:36Z)
• Who Are We Missing? A Principled Approach to Characterizing the Underrepresented Population [5.568543786710628]
  We introduce an optimization-based approach, Rashomon Set of Optimal Trees (ROOT), to characterize underrepresented groups. ROOT optimize the target subpopulation distribution by minimizing the variance of the target average treatment effect estimate. Our framework offers a systematic approach to enhance decision-making accuracy and inform future trials in diverse populations.
  arXiv  Detail & Related papers  (2024-01-25T21:11:35Z)
• Counterfactual Data Augmentation with Contrastive Learning [27.28511396131235]
  We introduce a model-agnostic data augmentation method that imputes the counterfactual outcomes for a selected subset of individuals. We use contrastive learning to learn a representation space and a similarity measure such that in the learned representation space close individuals identified by the learned similarity measure have similar potential outcomes. This property ensures reliable imputation of counterfactual outcomes for the individuals with close neighbors from the alternative treatment group.
  arXiv  Detail & Related papers  (2023-11-07T00:36:51Z)
• Asymptotically Unbiased Synthetic Control Methods by Distribution Matching [14.030354616779325]
  Existing Synthetic Control Methods (SCMs) suffer from an endogeneity problem, the correlation between the outcomes of untreated units and the error term of the synthetic control, which yields a bias in the treatment effect estimator. We propose a novel SCM based on density matching, assuming that the density of outcomes of the treated unit can be approximated by a weighted average of the joint density of untreated units.
  arXiv  Detail & Related papers  (2023-07-20T15:52:22Z)
• Improved Policy Evaluation for Randomized Trials of Algorithmic Resource Allocation [54.72195809248172]
  We present a new estimator leveraging our proposed novel concept, that involves retrospective reshuffling of participants across experimental arms at the end of an RCT. We prove theoretically that such an estimator is more accurate than common estimators based on sample means.
  arXiv  Detail & Related papers  (2023-02-06T05:17:22Z)
• Sample Constrained Treatment Effect Estimation [28.156207324508706]
  We focus on designing efficient randomized controlled trials, to accurately estimate the effect of some treatment on a population of $n$ individuals. In particular, we study sample-constrained treatment effect estimation, where we must select a subset of $s ll n$ individuals from the population to experiment on.
  arXiv  Detail & Related papers  (2022-10-12T21:13:47Z)
• Rethinking Collaborative Metric Learning: Toward an Efficient Alternative without Negative Sampling [156.7248383178991]
  Collaborative Metric Learning (CML) paradigm has aroused wide interest in the area of recommendation systems (RS) We find that negative sampling would lead to a biased estimation of the generalization error. Motivated by this, we propose an efficient alternative without negative sampling for CML named textitSampling-Free Collaborative Metric Learning (SFCML)
  arXiv  Detail & Related papers  (2022-06-23T08:50:22Z)
• Weighting-Based Treatment Effect Estimation via Distribution Learning [14.438302755258547]
  We develop a distribution learning-based weighting method for treatment effect estimation. Our method outperforms several cutting-edge weighting-only benchmarking methods. It maintains its advantage under a doubly-robust estimation framework.
  arXiv  Detail & Related papers  (2020-12-26T20:15:44Z)
• Robust Recursive Partitioning for Heterogeneous Treatment Effects with Uncertainty Quantification [84.53697297858146]
  Subgroup analysis of treatment effects plays an important role in applications from medicine to public policy to recommender systems. Most of the current methods of subgroup analysis begin with a particular algorithm for estimating individualized treatment effects (ITE) This paper develops a new method for subgroup analysis, R2P, that addresses all these weaknesses.
  arXiv  Detail & Related papers  (2020-06-14T14:50:02Z)
• Learning Decomposed Representation for Counterfactual Inference [53.36586760485262]
  The fundamental problem in treatment effect estimation from observational data is confounder identification and balancing. Most of the previous methods realized confounder balancing by treating all observed pre-treatment variables as confounders, ignoring further identifying confounders and non-confounders. We propose a synergistic learning framework to 1) identify confounders by learning representations of both confounders and non-confounders, 2) balance confounder with sample re-weighting technique, and simultaneously 3) estimate the treatment effect in observational studies via counterfactual inference.
  arXiv  Detail & Related papers  (2020-06-12T09:50:42Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.